Nuvectis gains global rights outside select Asian markets for oncology and complement disease therapies, with Haisco eligible for milestone payments and royalties
National conference brings together 160+ experts from six states to advance blood quality and safety standards
34% of pharma firms have already deployed function-specific AI, with drug discovery, clinical trials, and medical writing emerging as key high-impact use cases
The resolution significantly reduces a long-standing contingent liability from the company's books
The company plans to use this funding to boost AI capabilities, expand vernacular content ecosystem, accelerate product development, and scale user acquisition across Tier 2 and Tier 3 markets
In his 17-year career within Roche, Marco has held key global, regional, and affiliate leadership roles
The findings come from the first and only decentralized real-world study examining how HD chorea affects patients and caregivers and how treatment impacts quality of life
Approval makes it the first and only therapy in the EU indicated for both acute and chronic hepatitis C, supported by Phase 3 data
Industry members have until 15 July 2026 to submit feedback on proposals seeking additions, deletions and modifications to the Global Tender Enquiry
Bengaluru-based startup recognised for building autonomous AI agents for pharmaceutical and medtech commercial operations, joins select cohort of 40 startups in India-focused accelerator programme
Subscribe To Our Newsletter & Stay Updated
